Using mathematical modelling to estimate the impact of periodic presumptive treatment on the transmission of sexually transmitted infections and HIV among female sex workers

Sexually Transmitted Infections

Volumn 86, Issue 3, 2010, Pages 163-168

  Vickerman, Peter ^a   Ndowa, Francis ^b   O'Farrell, Nigel ^c   Steen, Richard ^b   Alary, Michel ^d   Delany Moretlwe, Sinead ^e  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c EALING HOSPITAL   (United Kingdom)

^d LAVAL UNIVERSITY   (Canada)

^e Reproductive Health and HIV Research Unit   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HAEMOPHILUS DUCREYI; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MALE; MATHEMATICAL MODEL; NEISSERIA GONORRHOEAE; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; SENSITIVITY ANALYSIS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOUTH AFRICA;

EID: 77953770102     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2008.034678     Document Type: Article

References (39)

1. O'Farrell N, Oula R, Morison L, et al. Periodic presumptive treatment for cervical infections in service women in 3 border provinces of Laos. Sex Transm Dis 2006;33:558-64. (Pubitemid 44318980)
2. Steen R, Vuylsteke B, DeCoito T, et al. Evidence of declining STD prevalence in a South African mining community following a core-group intervention. Sex Transm Dis 2000;27:1-8.
3. Labbe AC, Dzokoto D, Nzambi K, et al. A randomised placebo-controlled trial of routine monthly antibiotics against gonococcal and chlamydial infections among female sex workers in Ghana and Benin: intention-to-treat analysis. 15th Biennial Congress of the ISSTDR; 27-30 July 2003, Ottawa.
4. Vickerman P, Terris-Prestholt F, Delaney S, et al. Are targeted HIV prevention activities still cost-effective in high prevalence settings? Results from an STI treatment intervention for sex-workers in Hillbrow, South Africa. Sex Transm Dis 2006;33 (Suppl):S122-32.
5. Kaul R, Kimani J, Nagelkerke N, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infections in Kenyan sex workers: a randomized controlled trial. JAMA 2004;291:2555-62.
6. Cowan FM, Hargrove JW, Langhaug LF, et al. The appropriateness of core group interventions using presumptive periodic treatment among rural Zimbabwean women who exchange sex for gifts or money. J Acquir Immune Defic Syndr 2005;38:202-7.
7. World Health Organisation. Periodic presumptive treatment for sexually transmitted infections - programmatic and research guidelines. Geneva: World Health Organisation, 2006.
8. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001;28:579-97.
9. White RG, Orroth KK, Korenromp EL, et al. Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials. J Acquir Immune Defic Syndr 2004;37:1500-13.
10. Brunham RC, Pourbohloul B, Mak S, et al. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005;192:1836-44. (Pubitemid 41587838)
11. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatic vaccine. Nat Rev Immunol 2005;5:149-61. (Pubitemid 40208904)
12. Parks KS, Dixon PB, Richey CM, et al. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997;24:229-35.
13. Worm AM, Osterlind A. Azithromycin levels in cervical mucus and plasma after a single 1.0g oral dose for chlamydial cervicitis. Genitourin Med 1995;71:244-6.
14. Thornton AC, O'Mara EM Jr, Sorensen SJ, et al. Prevention of experimental Haemophilus ducreyi infection: a randomized, controlled clinical trial. J Infect Dis 1998;177:1608-13.
15. Alary M, Mukenge Tshibaka L, Bernier F, et al. Decline in the prevalence of HIV and sexually transmitted diseases among female sex workers in Cotonou, Benin, 1993-1999. AIDS 2002;16:463-70.
16. Lowndes C, Alary M, Labbe AC, et al. Male clients of female sex workers in Cotonou, Benin (West Africa): Contributions to the HIV epidemic and effect of targeted interventions (Abstract 0729). 15th Annual Congress of the International Society for Sexually Transmitted Diseases Research; Ottawa: 2003.
17. Lowndes CM, Alary M, Meda H, et al. Role of core and bridging groups in the transmission dynamics of HIV and STIs in Cotonou, Benin, West Africa. Sex Transm Infect 2002;78(Suppl 1):i69-77.
18. Korenromp EL, de Vlas SJ, Nagelkerke N, et al. Estimating the magnitude of STD cofactor effects on HIV transmission. Sex Transm Dis 2001;28:613-21.
19. Boily MC, Lowndes C, Alary M. The impact of HIV epidemic phases on the effectiveness of core group interventions: insights from mathematical models. Sex Transm Infect 2002;78(Suppl 1):i78-90.
20. White PJ, Ward H, Cassell JA, et al. Vicious and virtuous circles in the dynamics of infectious disease and the provision of health care: gonorrhea in Britain as an example. J Infect Dis 2005;192:824-36. (Pubitemid 41193080)
21. Holmes KK, Johnson DW, Trostle HJ. An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol 1970;91:170-4.
22. Hooper RR, Reynolds GH, Jones OG, et al. Cohort study of venereal disease. 1: the risk of gonorrhoea transmission from infected women to men. Am J Epidemiol 1978;108:136-44.
23. Korenromp EL, Sudaryo MK, de Vlas SJ, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS 2002;13:91-101.
24. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: a systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009;9:118-29.
25. Ruijs GJ, Schut IK, Schirm J, et al. Prevalence, incidence, and risk of acquiring urogenital gonococcal or chlamydial infection in prostitutes working in brothels. Genitourin Med 1988;64:49-51. (Pubitemid 18082120)
26. Lycke E, Löwhagen GB, Hallhagen G, et al. The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection. Sex Transm Dis 1980;7:6-10. (Pubitemid 10026057)
27. Quinn TC, Gaydos C, Shepherd ME, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996;276:1737-42. (Pubitemid 26423966)
28. Golden MR, Schillinger JA, Markowitz L, et al. Duration of untreated genital infections with chlamydia trachomatis: a review of the literature. Sex Transm Dis 2000;27:329-37. (Pubitemid 30439547)
29. Gomes JP, Borrego MJ, Atik B, et al. Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis. Microbes Infect 2006;8:16-26. (Pubitemid 43139288)
30. Plummer FA, D'Costa LJ, Nsanze H, et al. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya. Lancet 1983;2:1293-5.
31. Hanschell HM. Sulfanilamide in the treatment of chancroid. Lancet 1938;1:886-8.
32. Rauschkolb JE. Circumcision in treatment of chancroidal lesions of male genitalia. Arch Dermatol Syph 1939;39:319-28.
33. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191:1403-9.
34. Royce RA, Seña A, Cates W Jr, et al. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8.
35. Mastro TD, Satten GA, Nopkesorn T, et al. Probability of female-to-male transmission of HIV-1 in Thailand. Lancet 1994;343:204-7. (Pubitemid 24031642)
36. Fideli US, Allen SA, Musonda R, et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses 2001;17:901-10.
37. Morgan D, Mahe C, Mayanja B, et al. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002;16:597-603.
38. Post FA, Badri M, Wood R, et al. AIDS in Africa - survival according to AIDS-defining illness. S Afr Med J 2001;91:583-6. (Pubitemid 32707861)
39. Pinkerton SD, Abramson PR, Turk ME. Updated estimates of condom effectiveness. J Assoc Nurses AIDS Care 1998;9:88-9.